Intel cratered but STMicro just beat estimates — pairs trade the chip winners against the loser

Verdict: a coherent long-STM/short-INTC pair that isn't live yet — wait for STM's signal

The research stance is wait: the long-STMicro/short-Intel thesis is fundamentally coherent, but the entry is not live because STMicro closed at $46.74, about 3.7% below its 20-day EMA of roughly $48.46, and the setup has no measured track record since the raw and adjusted price series could not be reconciled. The strongest support is Intel's own filings — a $16.1B revenue quarter (up 18.8% sequentially) yet an $11.0B net loss and debt-to-equity jumping from 0.40 to 0.58 — which underwrites the idea's claim that Intel's pain is company-specific. The strongest counterargument is that the short leg may already be inflecting: Intel's free cash flow turned positive at $4.45B from negative $2.5B, its RSI of 18 flags deeply oversold conditions, and STMicro's own revenue has fallen from $17.3B to $11.8B over two years, undercutting its billing as the quality leg. Intel's provisional insider filings for the period ended September 30, 2026 show about $6.5M of net open-market selling, which mildly supports the short but is soft evidence. This is a watch-list idea, not an actionable signal — a daily close by STM above roughly $48.5 is the concrete condition to monitor.

Trade now: the pair thesis is intact, but the long leg hasn't triggered

**Wait.** The research thesis — long STMicroelectronics, short Intel — is coherent: the idea argues Intel's roughly 29% plunge reflects company-specific weakness (shrinking PC demand and its own supply problems) rather than a sector-wide collapse, and that STMicro's beat, with guidance for more than $4 billion in sales next quarter, shows other chipmakers executing. The latest Intel filings support the idiosyncratic-pain part: Q2 revenue of $16.1B (up 18.8% quarter over quarter) yet a net loss of $11.0B and net margin near negative 68%, with debt-to-equity jumping from about 0.40 to 0.58 in one quarter. But a good story is not a live entry, and today's entry conditions are only partially met. The missing leg is STM. The strategy requires STM's daily close **above** its 20-day EMA before entry; STM closed at $46.74 versus a 20-day EMA of about $48.46 — roughly 3.7% below the trigger. The Intel leg's condition (close below its 20-day EMA) is met, and trend-strength readings on both names (ADX above 18) are satisfied. So concretely, "waiting" means STM needs to close above ~$48.5 on the daily chart; until then, there is no signal, long or short. One scope note, stated once: this rule set could not be backtested because historical raw and adjusted prices for both INTC and STM use different bases, so no historical return, win rate, or drawdown evidence exists for this specific setup, and no robust parameter setup was established. Position sizing in the rule set caps any single position at 25% with a fixed 2% risk approach. The relevant horizon is the strategy's own timeframe — daily bars, with exits at a 90-bar holding limit, an 8% stop and a 12% profit cap on either leg. The downside that matters: Intel's short leg. Intel's RSI of 18 already signals deep oversold conditions (an RSI below 30 conventionally marks stretched selling), so a sharp mean-reversion rally is the principal risk to the short side. The exit rule — Intel crossing back above its 20-day EMA at ~$94.30, more than 43% above the current $65.76 close — is the tripwire that would end the short thesis. ### Technical details - **Entry (long STM, STM@1d):** close above 20-day EMA ($48.46; current $46.74, ~3.7% below — near), ADX(14) above 18 (current 21.4 — met), and close at or above the nearest support level ($46.00; current $46.74 — met). Status: waiting on the EMA condition. - **Entry (short INTC, INTC@1d):** close below 20-day EMA ($94.30; current $65.76 — met, ~30% below), ADX(14) above 18 (current 27.4 — met). Status: met. - **Exits:** INTC close crossing above its 20-day EMA ($94.30); STM close crossing below its 20-day EMA ($48.46); STM RSI(14) above 75 (current 44.6 — far); 90-bar holding limit; STM close at or above its 161.8% Fibonacci extension; stop if STM closes below its second-ranked support level; hard stops/takes at −8% and +12% unrealized P&L on either leg. - **Reward:risk as defined by the rule set:** a 12% take-profit against an 8% stop implies roughly 1.5-to-1 per leg. Because the backtest could not be run, no historical expectancy can be attached to these numbers. - Observations are daily bars as of 2026-10-31. Correlation between INTC and STM daily returns over the past 730 sessions is about 0.47 — meaningfully but not perfectly linked, which is what makes the pair partially sector-hedged rather than fully hedged.

The quality gap between STMicro and Intel is real, and the numbers back the short leg harder than the long leg

Takeaway: the thesis's core claim — that Intel's collapse is company-specific rather than a chip-industry downturn — is supported by diverging fundamentals: Intel's margins, balance sheet and insider posture are deteriorating while STMicro's demand news and balance sheet look resilient. Scope note: this setup is a watch-list idea, not a measured signal — historical performance was not computed because the raw and adjusted price series for both tickers sit on different bases, and no robust parameter setup was established. ### Intel's own filings confirm idiosyncratic distress Intel's most recent quarter (ended June 27, 2026) posted an $11.0B net loss and a net margin of roughly -68%, worse than the prior quarter's -27.5%, even as revenue grew 18.8% sequentially to $16.1B. A company losing money on a growing revenue base has a cost or write-down problem of its own, not a demand-cycle problem — which is exactly the idiosyncratic weakness the idea claims. If that continues, the short leg is fundamentally underwritten. ### Intel's leverage is rising fast Intel's debt-to-equity jumped 42.8% quarter over quarter to 0.577 in Q2 2026, from 0.404. Debt-to-equity measures how much of the company is financed by borrowing versus shareholder equity; Intel has nearly doubled this ratio from about 0.41 a year of restructuring ago. Rising leverage while unprofitable compresses options and raises equity risk — a structural, not just cyclical, argument for the short leg. ### Insider selling corroborates the bearish Intel view Filings for the period ended September 30, 2026 (provisional coverage) show net open-market insider selling at Intel of roughly $6.5M. Insiders with the best view of the turnaround are net sellers into the dip — consistent with the idea's view that the 29% plunge reflects real weakness, and inconsistent with a snap-back thesis the short would fear. ### STMicro's balance sheet can carry…

Scores

• Conviction score breakdown: 49
• Thesis support: 65
• Trade readiness: 30
• Risk quality: 45
• Fundamentals trend: 55

Watch items

• STM — Close vs 20-day EMA
• INTC — Close vs 20-day EMA
• INTC — RSI (14)
• INTC — Quarterly net income
• STM — Next-quarter sales guidance